Real-World Comparison of Maribavir to Foscarnet for the Treatment of Cytomegalovirus in Solid Organ and Hematopoietic Stem Cell Transplant Recipients

By sjmartinez • January 8, 2025

Ogawa L, Morinishi C, Multani A, Gaynor P, Beaird OE, Pham C, Schaenman JM. Real-World Comparison of Maribavir to Foscarnet for the Treatment of Cytomegalovirus in Solid Organ and Hematopoietic Stem Cell Transplant Recipients. Viruses. 2024 Dec 7;16(12):1889. doi: 10.3390/v16121889. PMID: 39772196.

Tags: CMV, foscarnet, immunocompromised, Infectious Diseases, maribavir, Publications, resistance

Impacts of neutralizing antibody responses on SARS-CoV-2 evolution and its associated disease progression

Wang L, Aliyari S, Sands N, Lee B, Yu A, Xia S, Jolkovsky EL, Zhang S, Kim J, Cheng G. Impacts of neutralizing antibody responses[...]

High HBV Seroprotection Rates in Infants Born to People with HIV and HBV Infection in Sub-Saharan Africa

Mohtashemi N, Spaczai J, Guo R, Tseng CH, Cambou MC, Emel L, Ship H, Zhang TH, Chiu SH, Stranix-Chibanda L, Chipato T, Kintu K, Manji[...]

Centering the voices of transwomen in HIV prevention

Clark J, Caceres C. Centering the voices of transwomen in HIV prevention. AIDS. 2025 Nov 15;39(14):2138-2139. doi: 10.1097/QAD.0000000000004354. Epub 2025 Oct 30. PMID: 41603875.